Контакты: +375 (44) 505-06-03, +375 (29) 614-61-49, лаборатория: +375 (44) 505-06-31. Время работы: 08:30 - 17:30
  • RU
  • DE
Контакты: +375 (44) 505-06-03, +375 (29) 614-61-49, лаборатория: +375 (44) 505-06-31. Время работы: 08:30 - 17:30
Letyal
  • Products
  • Manufacture
  • Laboratory
  • Services
  • News
  • Contacts
Menu
Letyal
  • RU
  • DE
Home page » Products » Amoksirifarm
Previous product
Baсtoseptolum
Back to products
Next product
Tricin-Bio

Amoksirifarm

The drug is prescribed to pigs, cattle for therapeutic purposes in diseases of the gastrointestinal tract, respiratory organs, genitourinary system, arthritis, endometritis, mastitis, MMA syndrome (mastitis-metritis-agalactia) and other diseases, the pathogens of which are sensitive to amoxicillin and rifampicin.

View instructions

  • Description
Description

Composition:
1.0 ml of the drug contains 150 mg of amoxicillin trihydrate, 50 mg of rifampicin and excipients as active ingredients: propylene glycol, isopropyl alcohol, ascorbic acid and water for injection.

Indications:
The drug is prescribed to pigs, cattle for therapeutic purposes in diseases of the gastrointestinal tract, respiratory organs, genitourinary system, arthritis, endometritis, mastitis, MMA syndrome (mastitis-metritis-agalactia) and other diseases, the pathogens of which are sensitive to amoxicillin and rifampicin.

The drug is produced in glass bottles of 10, 50 and 100 ml.

View instructions

Related products

Quick view
Close

Oflox 10% OR

Letazitrovet
Quick view
Close

Letazitrovet

Florofen 30%
Quick view
Close

Florofen 30%

Quick view
Close

Tricin-Bio

Ceftilum
Quick view
Close

Ceftilum

Drotul-plus
Quick view
Close

Drotul-plus

Tylosalum 20%
Quick view
Close

Tylosalum 20%

Quick view
Close

Letmoxiflox

2026
close
Start typing to see products you are looking for.
  • Products
  • Manufacture
  • Laboratory
  • Services
  • News
  • Contacts
Scroll To Top
We use cookies to provide you with the best experience on our website. By browsing this site, you agree to our use of cookies.
Accept